Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-κB, in mouse calvarial osteoblasts

Bone

Volumn 37, Issue 4, 2005, Pages 513-529

  Persson, Emma ^a,b   Voznesensky, Olga S ^c   Huang, Yu Feng ^c   Lerner, Ulf H ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF GÄVLE   (Sweden)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cytokines; Gene regulation; IL 6; Osteoblast; Transcription factors; VIP

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; ADENOSINE PHOSPHATE; FORSKOLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; KT 5720; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE; ROLIPRAM; STRESS ACTIVATED PROTEIN KINASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALVARIA; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; ONCOGENE C FOS; OSTEOBLAST; OSTEOCLAST; PHOSPHORYLATION; PROTEIN EXPRESSION;

3T3 CELLS; ANIMALS; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; INTERLEUKIN-6; MICE; NF-KAPPA B; OSTEOBLASTS; PHOSPHORYLATION; PLASMIDS; POLYMERASE CHAIN REACTION; SKULL; TRANSCRIPTION FACTOR AP-1; VASOACTIVE INTESTINAL PEPTIDE;

EID: 24944439902     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.04.043     Document Type: Article

References (52)

1. J. Ahlen, S. Andersson, H. Mukohyama, C. Roth, A. Bäckman, and H.H. Conaway Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones Bone 31 2002 242 251
2. P.M. Boonekamp, J.W. Hekkelman, J.W. Hamilton, D.V. Cohn, and R.L. Jilka Effect of culture on the hormone responsiveness of bone cells isolated by an improved sequential digestion procedure Proc. K. Ned. Akad. Wet. 87 1984 371 382
3. A.E. Christensen, F. Selheim, J. de Rooij, S. Dremier, F. Schwede, and K.K. Dao CAMP analog mapping of Epac1 and cAMP kinase J. Biol. Chem. 278 2003 35394 35402
4. M. Delgado, C. Abad, C. Martinez, J. Leceta, and R.P. Gomariz Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease Nat. Med. 7 2001 563 568
5. M. Delgado, and D. Ganea Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappaB, NF-AT, and early growth factors 2/3 J. Immunol. 166 2001 1028 1040
6. M. Delgado, and D. Ganea Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo J. Immunol. 167 2001 966 975
7. M. Delgado, G.M. Jonakait, and D. Ganea Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia Glia 39 2002 148 161
8. M. Delgado, J. Leceta, and D. Ganea Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia J. Leukocyte Biol. 73 2003 155 164
9. J.M. Enserink, A.E. Christensen, J. de Rooij, M. van Triest, F. Schwede, and H.G. Genieser A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK Nat. Cell Biol. 4 2002 901 906
10. A.D. Foey, S. Field, S. Ahmed, A. Jain, M. Feldmann, F.M. Brennan, and R. Williams Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis Arthritis Res. Ther. 5 2003 R317 R328
11. D. Ganea, and M. Delgado Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as modulators of both innate and adaptive immunity Crit. Rev. Oral Biol. Med. 13 2002 229 237
12. D. Ganea, R. Rodriguez, and M. Delgado Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: players in innate and adaptive immunity Cell. Mol. Biol. 49 2003 127 142
13. H. Gao, S. Parkin, P.F. Johnson, and R.C. Schwartz C/EBP gamma has a stimulatory role on the IL-6 and IL-8 promoters J. Biol. Chem. 277 2002 38827 38837
14. R.P. Gomariz, C. Martinez, C. Abad, J. Leceta, and M. Delgado Immunology of VIP: a review and therapeutical perspectives Curr. Pharm. Des. 7 2001 89 111
15. E.M. Greenfield, S.A. Gornik, M.C. Horowitz, H.J. Donahue, and S.M. Shaw Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA J. Bone Miner. Res. 8 1993 1163 1171
16. E.M. Greenfield, M.C. Horowitz, and S.A. Lavish Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction J. Biol. Chem. 271 1996 10984 10989
17. A. Grey, M.A. Mitnick, S. Shapses, A. Ellison, C. Gundberg, and K. Insogna Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption-a clinical research center study J. Clin. Endocrinol. Metab. 81 1996 3450 3454
18. A. Hernanz, S. Medina, E. Miguel, and E. Martin-Mola Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1beta, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients Regul. Pept. 115 2003 19 24
19. E.L. Hohmann, L. Levine, and A.H. Tashjian Vasoactive intestinal peptide stimulates bone resorption via a cyclic adenosine 3′,5′- monophosphate-dependent mechanism Endocrinology 112 1983 1233 1239
20. M.C. Horowitz, and J.A. Lorenzo Local regulators of bone: IL-1, TNF, lymphotoxin, interferon-γ, IL-8, IL-10, IL-4, the LIF/IL-6 family, and additional cytokines J.P. Bilezikan L.G. Raisz G.A. Rodan Principles of bone biology 2nd ed. 2002 Academic Press San Diego, USA 961 977
21. E.S. Hungness, G.J. Luo, T.A. Pritts, X. Sun, B.W. Robb, and D. Herschko Transcription factors C/EBP-beta and -delta regulate IL-6 production in IL-1beta-stimulated human enterocytes J. Cell. Physiol. 192 2002 64 70
22. H. Ihara, K. Hirukawa, S. Goto, and A. Togari ATP-stimulated interleukin-6 synthesis through P2Y receptors on human osteoblasts Biochem. Biophys. Res. Commun. 326 2005 329 334
23. M.G. Juarranz, B. Santiago, M. Torroba, I. Gutierrez-Canas, G. Palao, and M. Galindo Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells Rheumatology 43 2003 416 422
24. G. Karsenty, and E.F. Wagner Reaching a genetic and molecular understanding of skeletal development Dev. Cell 2 2002 389 406
25. A. Kondo, M. Mogi, Y. Koshihara, and A. Togari Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells Biochem. Pharmacol. 61 2001 319 326
26. M. Laburthe, and A. Couvineau Molecular pharmacology and structure of VPAC receptors for VIP and PACAP Regul. Pept. 108 2002 165 173
27. U.H. Lerner The role of skeletal nerve fibers in bone metabolism Endocrinologist 10 2000 377 382
28. U.H. Lerner Neuropeptidergic regulation of bone resorption and bone formation J. Musculoskel. Neuron Interact. 2 2002 440 447
29. U.H. Lerner, and P. Lundberg Kinins and neuro-osteogenic factors J.P. Bilezikan L.G. Raisz G.A. Rodan Principles of bone biology 2nd ed. 2002 Academic Press San Diego, USA 773 799
30. P. Lundberg, I. Boström, H. Mukohyama, A. Bjurholm, K. Smans, and U.H. Lerner Neuro-hormonal control of bone metabolism: vasoactive intestinal peptide stimulates alkaline phosphatase activity and mRNA expression in mouse calvarial osteoblasts as well as calcium accumulation mineralized bone nodules Regul. Pept. 85 1999 47 58
31. P. Lundberg, A. Lie, A. Bjurholm, P.P. Lehenkari, M.A. Horton, and U.H. Lerner Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts Bone 27 2000 803 810
32. P. Lundberg, I. Lundgren, H. Mukohyama, P.P. Lehenkari, M.A. Horton, and U.H. Lerner Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors Endocrinology 142 2001 339 347
33. S.C. Manolagas, and R.L. Jilka Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis N. Engl. J. Med. 332 1995 305 311
34. C. Martinez, M. Delgado, D. Pozo, J. Leceta, J.R. Calvo, and D. Ganea VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies J. Neuroimmunol. 85 1998 155 166
35. T. Matsusaka, K. Fujikawa, Y. Nishio, N. Mukaida, K. Matsushima, and T. Kishimoto Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8 Proc. Natl. Acad. Sci. U. S. A. 90 1993 10193 10197
36. B. Mayr, and M. Montminy Transcriptional regulation by the phosphorylation-dependent factor CREB Nat. Rev., Mol. Cell Biol. 2 2001 599 609
37. H. Mukohyama, M. Ransjö, H. Taniguchi, T. Ohyama, and U.H. Lerner The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK Biochem. Biophys. Res. Commun. 271 2000 158 163
38. T. Nakajima, S. Kinoshita, T. Sasagawa, K. Sasaki, M. Naruto, and T. Kishimoto Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6 Proc. Natl. Acad. Sci. 90 1993 2207 2211
39. P. Palmqvist, E. Persson, H.H. Conaway, and U.H. Lerner IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae J. Immunol. 169 2002 3353 3362
40. G. Passeri, G. Pini, L. Troiano, R. Vescovini, P. Sansoni, and M. Passeri Low vitamin D status, high bone turnover, and bone fractures in centenarians J. Clin. Endocrinol. Metab. 88 2003 5109 5115
41. J.H. Pollock, M.J. Blaha, S.A. Lavish, S. Stevenson, and E.M. Greenfield In vivo demonstration that parathyroid hormone and parathyroid hormone-related protein stimulate expression by osteoblasts of interleukin-6 and leukemia inhibitory factor J. Bone Miner. Res. 11 1996 754 759
42. D. Pozo, M. Delgado, C. Martinez, J. Leceta, R.P. Gomariz, and J.M. Guerrero Immunobiology of vasoactive intestinal peptide (VIP) Immunol. Today 21 2000 7 11
43. M. Ransjö, A. Lie, H. Mukohyama, P. Lundberg, and U.H. Lerner Microisolated mouse osteoclasts express VIP-1 and PACAP receptors Biochem. Biophys. Res. Commun. 274 2000 400 404
44. G.D. Roodman Studies in Paget's disease and their relevance to oncology Semin. Oncol. 28 Suppl. 11 2001 15 21
45. A.J. Shaywitz, and M.E. Greenberg CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals Annu. Rev. Biochem. 68 1999 821 861
46. G.J. Spencer, I.S. Hitchcock, and P.G. Genever Emerging neuroskeletal signalling pathways: a review FEBS Lett. 559 2004 6 12
47. W.C. Su, H.Y. Chou, C.J. Chang, Y.M. Lee, W.H. Chen, and K.H. Huang Differential activation of a C/EBP beta isoform by a novel redox switch may confer the lipopolysaccharide-inducible expression of interleukin-6 gene J. Biol. Chem. 278 2003 51150 51158
48. C. Trautwein, C. Caelles, P. van der Geer, T. Hunter, M. Karin, and M. Chojkier Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain Nature 364 1993 544 547
49. C. Trautwein, P. van der Geer, M. Karin, T. Hunter, and M. Chojkier Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA recognition elements J. Clin. Invest. 93 1994 2554 2561
50. D. Vaudry, B.J. Gonzalez, M. Basille, L. Yon, A. Fournier, and H. Vaudry Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions Pharmacol. Rev. 52 2000 269 324
51. M. Yin, S.Q. Yang, H.Z. Lin, M.D. Lane, S. Chatterjee, and A.M. Diehl Tumor necrosis factor (promotes nuclear localization of cytokine-inducible CCAAT/enhancer binding protein isoforms in hepatocytes J. Biol. Chem. 271 1996 17974 17978
52. F.J.T. Zwartkruis, and J.L. Bos Ras and Rap1: two highly related small GTPases with distinct function Exp. Cell Res. 253 1999 157 165